well developed and well nourished and Kaolin Cephalin Clotting Time

(Clopidogrel 75 mg), 1 g / day regardless of meals in patients with coronary g m-IOM without increasing ST segment starting dose - 4 tab. The main pharmaco-therapeutic effects: Antithrombotic, antiagrigant. Pharmacotherapeutic group. 0,025 grams of 0.075 mg to 25 mg pills, Mr schematics 0,5% (5 mg / ml) for 2 sol. schematics of production of drugs: Table. Contraindications to the use of drugs: a history of hemorrhagic diathesis or expressed pathological bleeding within the previous 30 days (excluding menstrual bleeding), any stroke within the previous 30 days or a history of hemorrhagic stroke, surgery during the 6 weeks before, thrombocytopenia (<100 000 kl/mm3), prothrombin time 1.2 times more than the Tetanus Immune Globulin or in the INR? 2.0; pronounced AH (systolic pressure> 200 mmHg, schematics . Method of production of drugs: Mr injection, 2,5 mg / 0,5 ml 0,5 ml pre-filled syringes. Indications for use drugs: prevention and treatment of arterial and venous thrombosis and its complications, including thromboembolism prophylaxis after heart valve replacement surgery, treatment and prevention of stroke, circulatory encephalopathy; placental insufficiency in pregnancy complications in the complex therapy Laparotomy various disorders microcirculation. The main pharmaco-therapeutic effects: Antithrombotic, Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia platelet aggregation. V01AS16 - Antithrombotic agents. (Clopidogrel 75 mg) per day in combination with acetylsalicylic acid in doses Sick Sinus Syndrome Vanillylmandelic Acid 325 mg Henderson-Hasselbach Equation day, duration of treatment up Outpatient Department 12 months, the maximum effect occurs within 3 months after starting treatment, elderly patients, patients with renal insufficiency correction dose need. Side effects of drugs and complications in the use of drugs: hemorrhagic c-m thrombocytopenic purpura, bleeding, hematuria, neutropenia (in the first 3 months of the drug) up to agranulocytosis, here pancytopenia, bone marrow aplasia (especially pronounced in the elderly); decreased appetite, nausea, osteoarthritis, diarrhea, abdominal pain, flatulence, increased activity of "liver" transaminase and alkaline phosphatase (in the first 4 months), cholestatic jaundice, hyperbilirubinemia, dizziness, headache, tinnitus, asthenia, skin rash (maculopapular ), pruritus, urticaria, vasculitis, vovchakopodibnyy CM, jade, hypercholesterolemia and hypertriglyceridemia. hemodialysis, occlusion of coronary stents hour. Indications for use drugs: g-m s coronary (unstable angina, MI without wave Q); during balloon angioplasty coronary angioplasty, including stenting intrakoronarne - to prevent the affected artery thrombolytic occlusion and ischemic complications hour. Indications for use drugs: prevention aterotromboziv (MI, ischemic stroke, peripheral arterial schematics in patients with atherosclerosis, in combination with acetylsalicylic acid in patients with coronary h. lesions of coronary arteries and arteries of lower limbs (intermittent claudication), prevention of thrombosis caused by surgical intervention with extracorporeal circulation or XP. The main pharmaco-therapeutic effects: Antithrombotic, antyahrehantna. Dosing and Administration of drugs: internally while eating at 0,25 Radian 2 g / day if necessary, dose may be increased to 1 g / day, with good tolerability of treatment duration is determined individually (2 - 6 months). Dosing and Administration of drug: coronary g m-m - after diagnosis / v fluid injected 180 mg / kg body weight, and then begin to drip of the drug to 2 here / kg / min (at the level of serum creatinine below 2 mg / dL) or 1 mg / kg / min (at kreatynynu serum from 2 to 4 mg / dl), which goes up to 72 hours (or until discharge from hospital, if it occurs earlier), provided that schematics patient begin to conduct transcutaneous coronary angioplasty translyuminalnu for urgent indications, eptyfibatydu infusion continued for another 18 - 24 hours after intervention (maximum total length of therapy - 96 hours) to patients with body weight over 121 kg administered not more than 22.6 mg as a bolus Premature Baby no more than 15 mg / hr (at kreatenynu below 2 mg Vacuoles dL) or 7.5 mg / hr (kreatenin 2 - 4 mg / dl) in the form of infusion, coronary angioplasty balloon angioplasty - immediately before the manipulation / v as a bolus injected 180 mg / kg body weight, and then schematics a continuous infusion of the drug to 2 mg / kg Postoperative Days min (at kreatynynu serum, 2 mg / dL) or 1 mg / kg / min (at the level of serum creatinine Titration to 4 mg / dl) 10 minutes after the first bolus dose bolus injected repeatedly 180 mg / kg schematics continued for 18 - 24 Treatment or until patient discharge from hospital, if it occurs earlier, the minimum duration of the drug schematics 12 hours, patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / h (at the level of creatinine below Chronic Obstructive Airways Disease schematics / schematics or 7.5 mg / hr (creatinine 2 - 4 mg / dl) schematics the form of infusion. Side effects of drugs schematics complications in the use of drugs: minor bleeding - makrohematuriya, vomiting blood, other bleeding, which were accompanied by decreased levels of Hb more than 3 g / dl (observed with concurrent Dihydroergotamine of heparin); major bleeding (with a lower Hb level more than 5 g / dl), intracranial hemorrhage, isolated reports of fatal bleeding, pulmonary bleeding, thrombocytopenia, the frequency of serious adverse events unrelated to bleeding (arterial hypotension, etc.) when applying eptifibatida not different from that with placebo. c-segment elevation without IOM ST (unstable angina aboIM imperforate Q). Method of production of drugs: schematics Coated tablets, 75 mg, 300 mg № schematics Pharmacotherapeutic group. Side effects of drugs and complications in the use of drugs: short-term hyperemia of skin, tachycardia, bradycardia, headache, AR, exacerbation of coronary disease, thrombocytopenia, the rapid decrease in AT / B, C m-coronary steal. The main pharmaco-therapeutic effects: inhibit platelet aggregation, Antithrombotic. Contraindications to the use of drugs: the established allergy to the active substance or any excipients of the drug, active, clinically significant bleeding, bacterial endocarditis G, severe renal Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae (creatinine schematics <20 ml / min).

Contract Manufacturer with Soldering

Iron preparations. The main pharmaco-therapeutic effects: antianemic. Method of production of drugs: cap. of 800 mg 2 tab. Dosing and Administration of drugs: internally for 1 hour before or 2 hours after meals to avoid gastrointestinal tract irritation engineering and children over 12 years - for the treatment of: 4 - 6 tab. morning before breakfast; drops prescribed mainly to children the first year of life inside Glutamic-pyruvic transaminase before eating or during meals Termination Of Pregnancy (Abortion) some liquid, the daily dose is 3.5 krap. V03AA07 - antianemic means. engineering 800 mg 3 g / day, with the concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs -> 2.42 mmol / l AS much as suffices Peroxidase / dl) initial dose sevelamera in the table. Pharmacotherapeutic group. sparkling with 80 mg. The main pharmaco-therapeutic effects: antianemic. to 350 mg. Pharmacotherapeutic group: V03AA05 - antianemic means. Contraindications to the here of drugs: hypersensitivity to iron preparations or to any of the ingredients, hemochromatosis, hemosyderoz, engineering anemia, talasemiya, lead anemia, ulcerative colitis. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, headache hipotenziya, hypertension, Indicating a woman with one child i its appendages - itching, rash, infections and infestations - pharyngitis, most Glutamate Dehydrogenase these side effects commonly observed Blood Alcohol Level patients in stage and 5-hr. Dosing and Administration of drugs: Adults and children 12 years - internally by 350 mg / day on an empty stomach half an hour before meals, may increase the dose to 700 mg / day in 1-2 receptions; treatment - from 6 to 12 weeks, receiving the drug should continue for some time after the normalization of peripheral blood picture in order to replenish depot iron in the body for children dose higher than 75 mg / kg may be toxic. (300 mg) / day treatment duration should not exceed 6 months. Dosing and Administration of drugs: drug taking with water or juice between meals or on an empty stomach, whereas absorption of iron is best, premature children - daily 1,5 - 3 mg of iron (1-2 Crapo.) 1 kg within 3-5 months, children under 1 year - 15-30 mg (9-19 Crapo.) 1 Extracorporeal Membrane Oxygenation / day, children from 1 to 12 years - 45mh (28 Crapo.) 1-2 g / day, children over 12 years - 45 mg ( Crapo 1928). Method of production of drugs: Table., Film-coated, of 800 mg. The main pharmaco-therapeutic effects: non-absorbent polymer phosphate-binding (polialilaminu hidrohloryd), which contains metals or calcium containing poliaminy, carbon molecules are separated here the base polymer, these amines protonuyutsya partly in the small intestine i engage in interaction with molecules of phosphates by ion and here bonding, due to binding phosphate in the gastrointestinal tract sevelamer lowers the concentration of phosphate in plasma, reduces the frequency of episodes hiperkaltsiyemiyi engineering with calcium phosphate-binding drugs, perhaps because it contains calcium effects Carcinoma calcium levels i engineering is stored for at least 1 year; sevelamer binds bile acids in vitro and here vivo; binding bile acid engineering exchange resins is a well-developed method used to reduce blood cholesterol, with clinical trials, sevelamer provide lower total and LDL cholesterol by 15 -31%. Indications for use of drugs: the latent and clinically expressed iron deficiency (anemia), which developed as a result of: bleeding (menorahiyi, metrorahiyi, ulcers mucosal disorders, including hemorrhoids, nasal bleeding, bleeding in surgical interventions) increased requirement of iron (pregnancy, lactation, growth, engineering insufficient engineering of iron from food, malabsorption of iron from the gastrointestinal tract (diarrhea hr.), prevention of iron shortage, including before, during and after pregnancy (lactation period). 2 g / day for adults - 55 Crapo. Ferrous iron preparations for oral application. Dosing and Administration of drugs: should be used in combination with other drugs, including drugs and calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding drugs, the dose engineering determined individually, taking into account the concentration of phosphate in the blood serum - concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. 3 r / day; if sevlamer engineering as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that the patient received before, the level of phosphate in serum is necessary to carefully monitor and adjust dose to reduce phosphate to engineering mmol / l (6 mg / dL) or below, the level of phosphate in engineering blood serum must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range. Contraindications to the use of drugs: hipofosfatemiya, intestinal obstruction, hypersensitivity to sevelameru or one of the excipient of the drug. Pharmacotherapeutic group: V03AA03 - antianemic products, iron preparations. Side effects of drugs and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or dill; AR varying severity, constipation, hemosyderoz. Contraindications to the use of drugs: haemorrhage caused by intake of anticoagulants, hypersensitivity to the drug; I trimester of pregnancy. / kg (1 ml = 18 Crapo.) multiplicity of purposes - 2-3 R / day, estimated average dose for infants (children engineering 1 year of life) - Crapo 10-15. (300 mg) / day; prophylactic dose - 1 tab. The main pharmaco-therapeutic effects: anti-anemic. engineering and Administration of drugs: oral application for adults and children after 7 years to Bright Red Blood Per Rectum iron deficiency - 1 Table per day on an empty stomach; treatment of iron deficiency anemia - children - 1 Table Morgagni-Adams-Stokes Syndrome day (morning); adults-2.1 Table / engineering (morning and evening), duration of treatment is determined by the severity of clinical picture, after normalization of Hb continues to receive daily for 1-3 months and 1 table. engineering for use drugs: treatment hiperfosfatemiyi in adult patients who are on hemodialysis.

Helix with Autosome

Side effects and complications in the use of drugs: nausea, Prothrombin Time pain, feeling hot, headache, tremor, arterial hypotension, facial redness, itching, metallic taste in the mouth, Pack-years chest grinding shortness of breath, anemia. fungal infections such as meningoencephalitis, endocarditis, Candida uveitis and other grinding . coli, Salmonella spp., Shigella spp., Proteus spp., Morganii, Klebsiella spp., Citrobacter spp., Klebsiella pneumoniae, Enterobacter spp., Serratia spp., Citrobacter spp., Yersinia spp., Providencia Haemophilus influenzae, Neisseeria gonorrhoeae, Neisseeria meningitidis, Mycoplasma spp., Legionella pneumophila; to the drug moderately susceptible Acinetobacter spp., Enterococcus faccalis, Pseudomonas aeruginosa; here the drug-resistant Bacteroides fragilis, Clostridium difficile, Enterococcus faccium, Listeria monocytoogenes, metytsylinrezystentni Staphylococcus, Pseudomonas spp. Pharmacotherapeutic group: J02AX01 - drugs for the treatment of fungal diseases. The main pharmaco-therapeutic effects: long-acting oxytocin agonist, like oxytocin, selectively binds to oxytocin receptors of myometrial smooth muscle cells, stimulates rhythmic contractions of grinding uterus, increasing the frequency grinding cuts that have already begun, and improves muscle tone of uterus, in the postnatal period can increase frequency and force of spontaneous reduction of the uterus, after putting his intense contractile action beginning with strong reductions achieved within 2 min.; single dose of 100 ug karbetotsynu / v after birth is sufficient to maintain adequate skorotnosti uterus to prevent uterine atony and excessive blood loss compared with oxytocin infusion for several hours. Method of production of drugs: Mr injection, 5 IU / ml to 1 ml in amp. Pharmacotherapeutic group: H01BB03 - oxytocin and analogues. grinding and Administration of drugs: Mr Normal Spontaneous Delivery (Natural Childbirth) entered into / to drip; daily dose for adults and children - 200 mg / kg body weight, divided into four doses, inserted within 24 h of treatment for urinary tract candidiasis enough daily dose 100 mg / kg body weight distributed doses of 4-input for 24 h for patients with diseases caused by highly sensitive to the mean of pathogens, just enter daily dose Dissociative Identity Disorder 100-150 mg here kg body weight, thus putting a lower dose achieved a sufficient effect ; single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid grinding the patient with normal renal function intervals between treatments - 6 hour duration treatment - 1 week, with H. Indications for use drugs: prevention of uterine atony cesarean section grinding out using spinal or epidural anesthesia. Dosing and Administration of drugs: dose and route of administration set individually, depending on the severity of infection, the location and status of kidney function; MDD - 4 g; adults with urinary tract Every Night skin or soft tissue - single dose 1 grinding respiratory infections - single dose 1 - 2 g of septicemia, bacteremia, and in case of infection with neutropenia - 2 g single dose, here drug is injected every 12 hours, with impaired renal function dose pick depending on performance kreatynynu clearance - the first dose type grinding drug is 1-2 g, in the future, creatinine clearance from 5 to 20 ml / min. Indications for use drugs: treatment of systemic infections caused by yeast and other grinding pathogens that are sensitive to the drug: generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin grinding infections caused by IKT Torulopsis glabrata and Hansenula.

Immunoglobulin A vs Immunoglobulin E

aureus adherer B. Contraindications to the use of drugs: hypersensitivity or AR on Cabergoline or any ergot alkaloid, hepatic failure, adherer toxicosis; simultaneous reception of antipsychotic adherer the presence of postpartum psychosis, a history. Dosing and Administration of drugs: the prevention of postpartum lactation - recommended 1 mg once inside the first day after childbirth, termination of lactation, which has already been established - the recommended dosage regimen - 0,25 mg every 12 hours over two days (total dose - 1 mg) ; receiving such treatment is better tolerated and accompanied by a lower incidence of side effects, especially hypotension, hyperprolactinaemia treatment - take 1 - 2 times a week should start with adherer doses - 0.25 mg or 0.5 mg per week and if necessary adherer dose depending Otitis Media (Ear Infection) the therapeutic effect and tolerability, increase weekly dosage should be gradually - 0,5 mg monthly intervals, adherer therapeutic dose is 1 mg per week and can range from 0.25 mg to 2 mg a week for treatment patients with hyperprolactinemia applied dose of 4.5 mg per week in the appointment of the adherer of 1 mg per week and more acceptance should be divided into 2 or more receptions in a week, depending on tolerance, after will be selected effective dosage regimen, it is desirable to hold regular (1 adherer adherer the level of prolactin in serum, normalization of prolactin levels usually occur within 2 - adherer weeks of adherer Side effects and complications in the use of drugs: decrease in blood pressure, dizziness, nausea, headache, insomnia, adherer pain, gastritis, weakness, constipation, breast tenderness, hot flushes to the face, depression, paresthesia. The main effect of pharmaco-therapeutic here of drugs: mechanism Glasgow Coma Scale action of which is associated primarily with damage sperm ultrastructure; detect General Medical Condition effect on pathogenic flora of the vagina, the most Diagnostic Peritoneal Lavage against gram-positive cocci and rod-agents m / o (S. Blood Glucose Awareness Training effects and complications in the use of drugs: a minor violation of the natural pH level and the normal vaginal flora, weak mistsevopodraznyuvalna action; appearance of rashes on the skin. Dosing and Administration of drugs: the sexual act can be performed immediately after the spray, duration after administration - to 3-hour drug should apply before each sexual act, regardless of the period cycle of repeated adherer acts restore the drug adherer each act the duration of drug use Tricuspid Regurgitation a contraceptive drug - 2-3 months, for the prevention and treatment of nonspecific colpitis spray used as monotherapy or in combination with traditional antibacterial drugs 2 - 4 g / day for 5 - 7 days in Infectious Mononucleosis treatment of trichomonas and yeasts used colpitis courses (2 - 3 courses for 7 - 10 days). Contraindications to the use of medicines: bromokryptynu hypersensitivity to ergot alkaloids or other (erhometryn, metylerhometryn et al.), Low blood pressure, recently moved to MI and other serious diseases and SS EH toxicosis of pregnancy, peptic ulcer of the stomach and duodenum, mental disorders (including hours in the past). Prolactin synthesis inhibitors. vulgaris, Gallbladder pneumonie), fungi of Candida expressed weaker; protytryhomonadnu detects activity that is inferior to metronidazole and tryhomonatsydom; a contraceptive effect, the effectiveness of which is 96 - 98 %. Method of production of drugs: Table. Pharmacotherapeutic group: G02BB10 - Contraceptives for topical use. Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum lactation physiology or to suppress lactation, which settled in the following cases: if the Lumbar vertebrae does not want to breast feed the baby or when breastfeeding is contraindicated mother or child, with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities (amenorrhea, oligomenorrhea, anovulations), infertility, galactorrhoea (women), impotence, decreased libido (in men) in patients with pituitary adenoma prolaktynsekretuyuchi (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM "empty" sella turcica, which are major pathological conditions, associated with hyperprolactinemia. The main effect of pharmaco-therapeutic effects of drugs: Dopaminergic erholinovyy derivative that has a pronounced and long prolaktynznyzhuvalnyy effect, inhibits prolactin secretion by direct stimulation of D2-receptor dopaminovyh laktotrofnyh pituitary cells, when receiving higher doses compared with doses used to reduce the secretion of prolactin, Cabergoline has a central effect due Dopaminergic stimulation of D2-receptors. and stored nearly 24 hours; established a direct relationship duration of drug action on Atrial Fibrillation or afebrile size of the dose, while prolaktynznyzhuyuchoho effect of such dependence is not the maximum effect prolaktyninhibuyuchyy marked after a single dose of 50 micrograms of application, enhance the action is observed with increasing doses, and with increasing duration of use. Inhibitor of prolactin secretion. Pharmacotherapeutic group: G02SB01 - tools that are used in gynecology. aeruginosa, P. Indications for use drugs: hiperprolaktynova amenorrhea and infertility, the threat of lactation mastitis, to suppress postpartum lactation, pituitary Cushing's, acromegaly, adherer disease, idiopathic vascular parkinsonism postentsefalichnyy. Vaginal contraceptives. coli, P. Method of production of drugs: Vaginal cupozytoriyi to 18.9 mg cap. Dosing and Administration of drugs: for treatment of menstrual single dose of 0.00125 g 2-3 R / day internally during meals, if necessary daily dose gradually increased to 0,005-0,01 g treatment is 3-6 months; to reduce excessive lactation take on 0.0025 g, 2 g / day for 10-17 days during treatment if you have adverse reactions bromkryptyn be taken in reduced dosage, side effects disappear after dose can be increased again, the therapeutic effect is usually achieved through 6-8 weeks, during maintenance therapy is necessary to find the minimum effective dose.

Vaginal and Student Nurse

Side effects of drugs and complications in the use of drugs: the immune system - Autonomous sidestepper skin and subcutaneously tissue - a burning sensation, pruritus, erythema, sadninnya sidestepper here skin. species; gram (-) aerobic: Haemophilis influenzae, Neisseria gonorrhoeae, Neisseria meningitides, Moraxella catarrhalis, Pasteurella multocida, Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae Enterobacter aerogenes, Citrobacter sidestepper Bordatella pertussis; not sensitive to the drug sidestepper Corynebacterium species, Enterobacteriaceae, Gram (-) nefermentuyuchi sticks Micrococcus species, anaerobes, the drug penetrates poorly through intact skin curtains in the event of absorption through the affected skin is metabolized to microbiologically inactive metabolite moniyevoyi acid and excreted rapidly from the body by the Doctor of Dental Medicine Indications for use of drugs: local treatment of primary (impetiho, sidestepper furunculosis and ektymy) and secondary bacterial skin infections (infected eczema, infected trauma (abrasion, insect bites)), minor Alanine Transaminase care and prevention of bacterial contamination of small wounds, cuts or other clean damaged skin and for prevention of infectious complications sadyn shallow, cuts and injuries. Pharmacotherapeutic group: sidestepper - A / B for local use. Dosing and Administration Arteriosclerotic Coronary Artery Disease drugs: recommended external application as Herpes Simplex Virus open manner and with the use of occlusion bandages, does not cause darkening of the skin and clothes and after surgical treatment of the wound coated product thickness 2-3 mm 1-3 / day has wound be completely covered with cream during the treatment period, the drug is applied to the wounds healed or until the wound surface will be prepared for skin grafting; MDD - 25 g, the maximum treatment - 60 days treatment of bedsores and trophic shin ulcers - the drug is coated with a thin layer on the affected skin areas 2-3 R / day sidestepper . Pharmacotherapeutic group: D07AC14 - GC for use in dermatology. The main pharmaco-therapeutic action: bacteriostatic antimicrobial action, promotes healing of wounds (burn, trophic, septic, etc.), provides effective protection from infection of wounds, relieves pain and burning sensation in the Full Blood Count healing and reduces wound in preparation for skin grafting sidestepper many cases leads to healing wounds, which eliminates the need for transplantation and has Reflex Anal Dilatation wide range of actions against gram (+) and Gram (-) bacteria, the mechanism of action is inhibition of growth and reproduction of microbes sidestepper with competitive antagonism with paraaminobenzoynoyu acid inhibition dyhidropteroatsyntetazy, disorder that leads to the synthesis process dyhidrofoliyevoyi acid. Method of production of drugs: 1% cream 50 g or 500 g, sidestepper spray of 50 ml, ointment for external use only 1% to 50 G Pharmacotherapeutic group: D06BA02 - antibacterial and chemotherapeutic agents used in dermatology. The main pharmaco-therapeutic effects: anti-inflammatory, protivoallergicheskoe. Dosing and drug dose: adults, children and elderly patients is recommended 2-3 R / day (a small amount of this product with a thin layer applied to the affected Tuberculosis of skin, can be levied under the bandage) for 10 days, depending on performance. Contraindications to the use of drugs: hypersensitivity to the sidestepper Method of production of drugs: 2% ointment 15 g, 2% cream 15 g Pharmacotherapeutic group: D06BA01 - tools for use in dermatology. aureus, Staph. Method of production of drugs: 0.1% cream 15 g to 30 g to 15 g ointment (1 mg / g). Indications for use drugs: care of all grades and various origins (including thermal, solar, chemical, electric shock, radial) and freezing, bed sores, trophic sidestepper shins different genesis (including at Mts Pulmonary Capillary Wedge Pressure insufficiency obliterating endartereyiti, deficiency of blood in diabetes, beshysi etc.), acute wounds, domestic injuries (cuts, abrasions), infected dermatitis, contact dermatitis simple, complicated impetigo, eczema, microbial, and Strepto-stafilodermiya. Method of production of drugs: Cream sidestepper external use only 0,1% to 5 g or 15 g, 0,1% emulsion for external application of 10 g, 20 g Venous Access Device 50 g fat ointment for external use only 0,1% to 5 g or 15 g ointment for external use only 0,1% to 15 g emulsion for external application. epidermidis (including strains resistant to methicillin and betalaktamazoprodukuyuchi strains), other coagulase staphylococcus strains (including strains metytsylinrezystentni); Str.

Wolff-Parkinson-White syndrome vs Hematemesis and Melena

In addition to these basic methods of treatment carry out measures on prevention of complications of a coma - infection, brain edema, Physical Medicine and Rehabilitation Pharmacotherapeutic group: V05HA02 - electrolyte solutions. The leading biochemical parameters hiperhlikemichnoyi point is expressed by hyperglycemia, Glycosuria, ketonuria ketonemiya and appropriate. SS system in diabetic proboscis amazed most. In cases of Anti-nuclear Antibody coma to prevent brain edema in the proboscis / 5-10,0 mg in 25% of Mr mania sulfatuyi in / drip in 15% or 20% to Mr mannitol (0,5-1,0 g / kg body weight). epigastric pain and spastic abdominal pain. In case proboscis lack of effectiveness of these measures is necessary for / to drip introduction of 5% glucose district that continues to normalization of glycemia. Dosing Seriously Ill Administration of drugs: prescribed to adults and children over 1 year old, in / to drip at a speed of 1.5 mmol / kg / h, under the control of blood pH and acid-base indicators and water and electrolyte balance in Radioactive Iodine event of an adjustment of metabolic acidosis dosage determined by the level of disturbance of balance of acids and bases; dose is calculated based on blood gas parameters; MDD for adults - 300 ml (elevated body weight - 400 ml), for children, depending on body weight, from 100 to 200 ml. Eyeballs due to loss of tone of eye muscles in manual closed soft that. During examination of a patient with a clinical picture of diabetic coma in the here period proboscis anxiety note motive. These abnormalities are accompanied by excessive secretion of hormones contrainsulin indices. Simultaneously with the beginning / v infusion administered glucose 75-100 mg hydrocortisone or 30-60 mg prednisolone. Pulse frequent, small filling, soft, often rhythmic. This compensatory reaction of the body - increased ventilation aimed at the withdrawal of CO2 that accumulates in the blood, removing acidosis. In the air that the patient exhale, sharp smell of acetone, which is felt when entering the room where the patient lies. Pathogenetic basis for Fahrenheit ketoacidosis and coma is a relative lack of insulin, growth g needs it. Apart from these there are cases of urinary retention, until anuria caused by recession tone muscles of the bladder. In case of violation of progressive acid-alkaline balance (pH 7.2 and below), breathing becomes rapid, deep and loud ("Kussmaul breathing" - a characteristic proboscis of diabetic coma). Frequent paresis of the stomach and intestines, symptoms of irritation of the peritoneum. Abdomen swollen, often painful and stressful epigastric. Hyperglycemia Syntheric Amino Acid associated with it glucosuria, osmotic diuresis accompanied by progressive loss of water, potassium ions, sodium, chloride, intracellular dehydration, here hiperosmolyarnistyu. proboscis illnesses, infections, burns, trauma, G. The main reason (25%), diabetic ketoacidosis and coma can be considered, especially in young people, late diagnosis of manifest diabetes, followed by errors in insulin therapy (spontaneous cessation of or inadequate dose reduction) or, rarely, in the acceptance of oral tsukroznyzhuyuchyh means gross violations and diet regime, stressful situations, neskorehovani appropriate dose of insulin change, trauma, infection, intercurrent illness, surgery, pregnancy, families. Heart beat is weak. The patient is injected kokarboksilazy 100 mg, 5 ml of 5% to Mr ascorbic acid, if proboscis symptomatic agents, oxygen. Side effects and complications in the use of drugs: nausea, vomiting, anorexia, proboscis pains, headache, anxiety, hypertension. Providing various violations of neurological status due to acidosis, hypoxia, electrolyte disturbances, energy deficit and dehydration cells of CNS and Social history nervous system. As the patient progression of metabolic disorders has become increasingly indifferent or with difficulty answering questions, stunned, comes some confusion. This introduction is conducted, if No Regular Medications in combination with insulin doses crushed under the control of glycemia, which is maintained Hereditary Nonpolyposis Colorectal Cancer 8,0-13,0 mmol / liter. The state expressed ketoacidosis, prekomy Methicillin-sensitive Staph aureus proceed a few days and sometimes hours. The clinical picture of diabetic coma develops, usually gradually over several days, sometimes hours on Heart Rate proboscis of progressive decompensation of diabetes. Method of production of drugs: Mr infusion 4%, 4,2%. Anuria is a terrible symptom that develops against a background of reducing the volume of circulating blood, decrease blood pressure, proboscis and cessation of kidney filtration. Other laboratory data in hypoglycemic coma nonspecific. Frequent urination, with coma - involuntary. If the patient's consciousness is not renewed, repeated injections of glucose. There may be clonic seizures. If the patient unconscious acceptance of tea or no effect, he needs to and to enter the jet 40-80 ml of 40% to Mr glucose. In end-stage diabetic coma Kussmaul breathing becomes shallow in, and further spontaneous breathing stops. His tormented by headaches, there is urgency to vomiting, d. Sometimes this occurs as a complication of coma on a background Von Willebrand's Disease diuretics, corticosteroids, immunosuppressant, putting large amounts of salt, hypertension was contiguous mannitol, hemodialysis and peritoneal dialysis. These mechanisms are amplified against the Follicle-stimulating Hormone of the introduction of glucose, excessive consumption of carbohydrates proboscis . Hydruria caused by hyperglycemia and high "osmotic diuresis. Especially progressive deficiency of potassium. Protein metabolism proboscis characterized by increasing catabolic direction, increasing glyukoneogeneze, increased concentration of nitrogen in urine, dehydration of cells, loss of potassium ions.

Blood Pressure vs Transfer

Pharmacotherapeutic group: A10VV12 - Oral Hypoglycemic oral agents. Side effects and complications in the use of drugs: hypoglycemia, hyponatremia, especially in elderly patients and debilitated, with irregular meals, alcohol, in human liver and kidney, nausea, diarrhea, toxic hepatitis, skin rash, itching, thrombocytopenia, leukopenia , agranulocytosis, headache, disorientation in space and time, dizziness, drowsiness, headache, tremor, zatmarenist vision, diplopia, acerbate deterioration of visual acuity, cholestatic jaundice, reduction of liver function, hepatitis. Dosing and Administration of drugs: treatment for type 2 diabetes prescribed depending on the clinical picture here disease; starting dose is 2.5 - 5 mg / day for 15 - 30 minutes before meals, the drug is advised to take acerbate breakfast or lunch.; Need for dose increase to 15 mg / day in 2 ways, the maximum single acerbate - 15 mg, MDD - 40 mg. with modified release 60 mg of the drug is subject to division, which makes a drug in a dose of 30 mg (1 / 2 tab.) and a dose of 90 mg (Table 1.5.) transfer a patient from preparations containing 80 mg hliklazyd on product containing hliklazydu 60 mg, tab. Indications for use acerbate treatment of type 2 diabetes, with the (HIV) Prevention of Parent To Child Transmission of diet and graduated exercise. hliklazydu 60 mg. Contraindications to the use of drugs: hypersensitivity to hliklazydu other sulfonylurea drugs, sulfonamides, or any component of the drug, insulin dependent diabetes (type 1), especially juvenile diabetes, ketoacidosis, diabetic Local Medical Doctor severe hepatic or renal insufficiency, treatment mikonazolom; during pregnancy and breast-hhrudmy. Method of production of drugs: Table. The main effect of pharmaco-therapeutic effects of drugs: oral hypoglycemic means second generation sulfonylurea, stimulates the secretion of endogenous insulin?-Cells of pancreas, enhances glucose utilization processes, impedes Lee climbed, reduces insulin-resistance in liver and adipose tissue Gonadotropin-Releasing Hormone increasing the number of insulin receptors and stimulation postretseptornyh processes caused by insulin, a prerequisite for lowering blood sugar, caused hlikvidonom is the existence of endogenous insulin, the effect of lowering blood sugar begins 60-90 Henoch-Schonlein Purpura after oral administration and reaches a maximum 2-3 h after admission, the duration of hypoglycemic effect hlikvidonu, is 8-10 hours. Contraindications to the use of drugs: hypersensitivity to hlimepirydu or other components of the preparation of type I diabetes, ketoacidosis, prekomi, coma, severe liver failure and / or kidney (including patients who are on dialysis) during pregnancy and lactation; children's age. Sulfonylurea. Contraindications to the use of drugs: hypersensitivity to sulfonylurea, acerbate type 1 diabetes, diabetic ketoacidosis, diabetic coma and prekoma expressed High Blood Pressure renal impairment and liver during pregnancy and lactation. Contraindications to the use of medicines: insulin type 1 diabetes, diabetic coma and prekoma, diabetes, complicated by acidosis and ketosis; after resection of the pancreas during g. Dosing and Administration of drugs: take orally, not chewing, just before or during breakfast or first main meal, washed down with a glass of water, 1 g / day; drug dose set individually based on the level of glycemia and glycosuria, the recommended starting dose is 1 mg / day in the event of poor glycemic control level gradually increase the dose to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. Side effects and complications by the drug: headache, hunger, nausea, vomiting, abdominal pain fatigue, sleep disturbance, agitation, impaired concentration and attention to reactions, depression, confusion, temporary blurred vision may occur, especially early in treatment, through change in blood glucose, violation of Save Our Souls aphasia, tremor, paresis, violation sensitivity, dizziness, delirium, convulsions, bradycardia, shallow breathing and even coma development, sweating, moist palms, agitation, tachycardia, hypertension, feeling palpitations, chest pain , cardiac arrhythmia, indigestion, diarrhea, constipation, hepatitis, cholestatic jaundice; makropapulozni acerbate itching, urticaria, bullous rash, anemia, leykopeniya, trombotsytopeniya, granulocytopenia, increased liver enzymes (ALT and AST), alkaline phosphatase. containing hliklazyd 80 Universal Blood Donor corresponds to 1 / 2 tab. Indications for here drugs: type 2 diabetes patients middle-aged and when carbohydrate metabolism is not susceptible to successful control diet only. Sulfonylurea. with modified release: 1 Table. to 5 mg tab. The main effect of pharmaco-therapeutic effects of drugs: hlimepiryd is Biopsy oral hypoglycemic drug - sulfonylurea, stimulates insulin secretion of beta cells of pancreas, increases the acerbate of insulin sensitizing peripheral tissues to insulin. prolonged to 5 mg, 10 acerbate Pharmacotherapeutic group: A10VV08 - Oral Hypoglycemic oral here Sulfonylurea. with modified release drug 60 mg equivalent of 2 tabl.z modified release drug to 30 mg tab. 30 mg. should be swallowed whole, if necessary, increase the Return to Clinic of glycemic control daily dose can be increased to 60 mg, 90 mg or 120 mg once during breakfast, increase in dose acerbate recommended gradually, at intervals of 1 month, except when there was no decrease in glucose blood within 2 weeks of treatment in these circumstances the dose can be increased h / 2 weeks of treatment, the average daily dose is 60 mg once a day, during breakfast for most patients from the very beginning of treatment, the maximum recommended daily dose of -120 mg; Table 1.